Could a diabetes pill help teens with fatty liver? new study aims to find out.
Disease control
Recruiting now
This study tests whether a type 2 diabetes drug (SGLT2 inhibitor) can reduce liver fat in 40 adolescents aged 16-21 with obesity and non-alcoholic fatty liver disease (NAFLD). Participants will receive either the drug or a placebo for 26 weeks. The main goal is to see if the drug…
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated May 26, 2026 08:10 UTC